GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹515 Cr | ₹456 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr |
What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹515 Cr |
| Mar2025 | ₹456 Cr |
| Mar2024 | ₹387 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹355 Cr |
How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹515 Cr | 12.92 | |
| Mar2025 | ₹456 Cr | 17.78 | |
| Mar2024 | ₹387 Cr | 9.46 | |
| Mar2023 | ₹354 Cr | -0.26 | |
| Mar2022 | ₹355 Cr | - | |
Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,185.2 Cr | 7% | 6.7% | -4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 7% |
6.7% |
-4.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses